İstanbul Journal of Pharmacy

GÖNDERBİLGİ
EnglishTürkçe

Araştırma Makalesi


DOI :10.26650/IstanbulJPharm.2025.1547133   IUP :10.26650/IstanbulJPharm.2025.1547133    Tam Metin (PDF)

Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study

Eren Demirpolat, Nisa Güneş

Background and Aims: Potential drug-drug interactions (pDDIs) might change treatment outcome. pDDIs are frequently encountered in patients with renal dysfunction. Our aim is to analyse the compatibility of drug interaction databases and investigate drug interactions in nephrology patients.

Methods: In our study, the treatment orders of patients and a comparison of four databases (Uptodate® , Micromedex® , RxMediaPharma® , Drugs.com) were analysed retrospectively. 152 patients who were treated in a University Nephrology inpatient service between January 2018 and 2020 were included.

Results: At least one pDDI was detected in 129 (84.9%) patients. The median age of patients was 62, and the interquartile range was 50-72. A total of 1088 pDDIs belonging to 616 different drug pairs were detected. The age values of patients with at least one pDDI were found to be higher than the group without interaction (p=0.005). The total number of interactions in 4 different databases was significantly higher among patients with polypharmacy and comorbidity (p<0.001). There was an agreement rate of 22% in terms of detecting drug interactions in 4 databases. There was an insignificant level of agreement at the rate of 5.2% in terms of similarity in severity levels. In the pairwise comparison of databases, the highest agreement for identifying interactions (65.3%) and severity levels (21.4%) was between Uptodate® and RxMediaPharma® .

Conclusion: The frequency of interaction is high in nephrology. More than one database should be checked due to the low compliance rates between databases by the clinical pharmacist.

Anahtar Kelimeler: Clinical pharmacy, Concordance, Drug-drug interactions, Nephrology, Interaction databases

PDF Görünüm

Referanslar

  • Abbas, A., Al-Shaibi, S., Sankaralingam, S., Awaisu, A., Kattezhathu, V. S., Wongwi-watthananukit, S., & Owusu, Y. B. (2022). Determination of potential drug-drug interactions in prescription orders dispensed in a communitY pharmacY setting using Micromedex® and Lexicomp®: a retrospective observational studY. International Journal of clinical pharmacy, 44(2), 348-356. https://doi. org/10.1007/s11096-021-01346-8 google scholar
  • Aghili, M., & Kasturirangan, M. N. (2021). Management of Drug-Drug Interactions among Critically Ill Patients with Chronic KidneY Disease: Impact of Clinical Pharmacist's Interventions. Indian Journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 25(11), 1226-1231. https://doi.org/10.5005/jp-journals-10071-23919 google scholar
  • Al-Ramahi, R., Raddad, A. R., Rashed, A. O., Bsharat, A., Abu-Ghazaleh, D., Yasin, E., & Shehab, O. (2016). Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients. BMC nephrology, 17, 96. https://doi.org/10. 1186/s12882-016-0317-4 google scholar
  • Bahçecioğlu, Ö.F. (2021). Hematoloji Servisinde Yatan Hastalarda Potansiyel İlaç-İlaç Etkileşimlerinin Değerlendirilmesi. (Uzmanlık Tezi). Ulusal tez merkezi. (Tez no 707675). google scholar
  • BektaY, M. Y., Buker Cakir, A., Gursu, M., Kazancioglu, R., & Izzettin, F. V. (2024). An Assessment of Different Decision Support Software from the Perspec-tive of Potential Drug-Drug Interactions in Patients with Chronic Kidney Diseases. Pharmaceuticals (Basel, Switzerland), 17(5), 562. https://doi.org/10. 3390/ph17050562 google scholar
  • Biase, T. M. M. A., Brunieri, G. S., Silva, M. T., & Galvao, T. F. (2022). Potential Drug Interactions in Adults Living in Manaus: A Real-World Comparison of Two Databases, 2019. Turkish Journal of pharmaceutical sciences, 19(5), 543-551. https://doi.org/10.4274/tjps.galenos.2021.96603 google scholar
  • Cheng, F., Li, Q., Wang, J., Wang, Z., Zeng, F., & Zhang, Y. (2021). The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic KidneY Disease: A Systematic Review and Meta-Analysis. Thera-peutics and clinical risk management, 17, 1321-1331. https://doi.org/10.2147/ TCRM.S344592 google scholar
  • Donner, A., & Eliasziw, M. (1992). A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance-testing and sample size estimation. Statistics in medicine, 11(11), 1511-1519. https:// doi.org/10.1002/sim.4780111109 google scholar
  • Ergun, Y., Yildirim Ozdemir, N., Toptas, S., Kurtipek, A., Eren, T., Yazici, O., Sendur, M. A., Akinci, B., Ucar, G., Oksuzoglu, B., & Uncu, D. (2019). Drug-drug interac-tions in patients using tYrosine kinase inhibitors: A multicenter retrospective studY. Journal of B.U.ON. : official Journal of the Balkan Union of Oncol-ogy, 24(4), 1719-1726. google scholar
  • Fasipe, O.J., OlaYemi, S.O., AkinYede, A.A., Osho, P.O., Ibiyemi-Fasipe, O.B., & Osho, E.S. (2018). How do we prevent the burden of extremely harmful and clini-cally nonbeneficial drug-drug interactions among chronic kidney disease patients? Toxicology Research and Application, 2, 1-14. https://doi.org/10.1177/ 2397847318794861 google scholar
  • GünaY, A., Demirpolat, E., Ünal, A., & AYcan, M. B. (2022). A comparison of four drug-drug interaction databases for patients undergoing haematopoietic stem cell transplantation. Journal of clinical pharmacy and therapeutics, 47(10), 17111719. https://doi.org/10.1111/jcpt.13728 google scholar
  • Habet S. (2021). Narrow Therapeutic Index drugs: clinical pharmacology perspec-tive. The Journal of pharmacy and pharmacology, 73(10), 1285-1291. https:// doi.org/10.1093/jpp/rgab102 google scholar
  • Halkin, H., Katzir, I., Kurman, I., Jan, J., & Malkin, B. B. (2001). Preventing drug interac-tions bY online prescription screening in communitY pharmacies and medical practices. Clinical pharmacology and therapeutics, 69(4), 260-265. https://doi. org/10.1067/mcp.2001.114228 google scholar
  • Hegde, S., UdaYkumar, P., & Manjuprasad, M.S. (2015). Potential drug interactions in chronic kidney disease patients - A cross sectional studY. International Journal of Recent Trends in Science And Technology,16(1),56-60. google scholar
  • Karas S., Jr (1981). The potential for drug interactions. Annals of emergency medi-cine, 10(12), 627-630. https://doi.org/10.1016/s0196-0644(81)80085-6 google scholar
  • Khamas, S.S., Lebadi, M., Ashouri, A., Mokhtari, G., & Jafari, A., (2021). Evaluation of Potential Drug-Drug Interactions among Patients of the NephrologY and KidneY Transplant Wards of a Major Teaching Hospital in Iran. Journal of Phar-maceutical Research International, 33(38B),66-78. https://doi.org/10.9734/jpri/ 2021/v33i38B32100 google scholar
  • Kheshti, R., Aalipour, M., & Namazi, S. (2016). A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensive-ness. Journal of research in pharmacy practice, 5(4), 257-263. https://doi.org/ 10.4103/2279-042X.192461 google scholar
  • Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159-174. google scholar
  • Liu, X. X., Wang, H. X., Hu, Y. Y., Zhu, X. T., Tan, X., Yang, Y., Hang, Y. F., & Zhu, J. G. (2021). Drug-related problems identified bY clinical pharmacists in nephrologY department of a tertiarY hospital in China-a single center studY. Annals of palliative medicine, 10(8), 8701-8708. https://doi.org/10.21037/apm-21-817 google scholar
  • Marquito, A. B., Fernandes, N. M. S., Colugnati, F. A. B., & Paula, R. B. (2014). Identi-fying potential drug interactions in chronic kidney disease patients. Braz. J. Nephrol., 36(1), 26-34. https://doi.org/10.5935/0101-2800.20140006 google scholar
  • Mason, N. A., & Bakus, J. L. (2010). Strategies for reducing polYpharmacY and other medication-related problems in chronic kidneY disease. Seminars in dialy-sis, 23(1), 55-61. https://doi.org/10.1111/j.1525-139X.2009.00629.x google scholar
  • Okoro, R.N., & Farate, V.T. (2019). Evaluation of potential drug-drug interactions among patients with chronic kidneY disease in northeastern Nigeria. African Journal of Nephrology,22(1),77-81. https://doi.org/10.21804/22-1-3577 google scholar
  • Özdamar, E.N., & Özdamar, İ. (2021). Evaluation of the potential drug-drug interactions at orthopedics and traumatologY outpatient clinics of a tertiarY care hospital. Cukurova Med J,46(2),601-609. https://doi.org/10.17826/cumj.865824 google scholar
  • RxMediaPharma® İnteractive Drug İnformation Database, 2025. Editor : Prof. Dr. Levent Üstünes, GEMAŞ Genel Mühendislik A.Ş., Bornova, İzmir, ISBN: 978-975-6168-22-6 google scholar
  • Sancar, M., Kaşik, A., OkuYan, B., Batuhan, S., & Izzettin, F. V. (2019). Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Com-munitY Pharmacy Setting. Turkish Journal of pharmaceutical sciences, 16(1), 14-19. https://doi.org/10.4274/tjps.30932 google scholar
  • Scheife, R. T., Hines, L. E., BoYce, R. D., Chung, S. P., Momper, J. D., Sommer, C. D., AbernethY, D. R., Horn, J. R., Sklar, S. J., Wong, S. K., Jones, G., Brown, M. L., Grizzle, A. J., Comes, S., Wilkins, T. L., Borst, C., Wittie, M. A., & Malone, D. C. (2015). Consensus recommendations for sYstematic evaluation of drug-drug interaction evidence for clinical decision support. Drug safety, 38(2), 197-206. https://doi.org/10.1007/s40264-014-0262-8 google scholar
  • Sgnaolin, V., Sgnaolin, V., Engroffi, P., Decarli A. G., Figueiredo, A. E. P. L., & Engroff P (2014). Assessment of used medications and drug-drug interactions among chronic renal failure patients. Scientia Medica, 24(4),329-335. https:// doı:10.15448/1980-6108.2014.4.17637 google scholar
  • Sommer, J., Seeling, A., & Rupprecht, H. (2020). Adverse Drug Events in Patients with Chronic Kidney Disease Associated with Multiple Drug Interactions and Polypharmacy. Drugs & aging, 37(5), 359-372. https://doi.org/10.1007/s40266-020-00747-0 google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Demirpolat, E., & Güneş, N. (2025). Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study. İstanbul Journal of Pharmacy, 55(1), 1-9. https://doi.org/10.26650/IstanbulJPharm.2025.1547133


AMA

Demirpolat E, Güneş N. Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study. İstanbul Journal of Pharmacy. 2025;55(1):1-9. https://doi.org/10.26650/IstanbulJPharm.2025.1547133


ABNT

Demirpolat, E.; Güneş, N. Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study. İstanbul Journal of Pharmacy, [Publisher Location], v. 55, n. 1, p. 1-9, 2025.


Chicago: Author-Date Style

Demirpolat, Eren, and Nisa Güneş. 2025. “Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study.” İstanbul Journal of Pharmacy 55, no. 1: 1-9. https://doi.org/10.26650/IstanbulJPharm.2025.1547133


Chicago: Humanities Style

Demirpolat, Eren, and Nisa Güneş. “Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study.” İstanbul Journal of Pharmacy 55, no. 1 (Aug. 2025): 1-9. https://doi.org/10.26650/IstanbulJPharm.2025.1547133


Harvard: Australian Style

Demirpolat, E & Güneş, N 2025, 'Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study', İstanbul Journal of Pharmacy, vol. 55, no. 1, pp. 1-9, viewed 17 Aug. 2025, https://doi.org/10.26650/IstanbulJPharm.2025.1547133


Harvard: Author-Date Style

Demirpolat, E. and Güneş, N. (2025) ‘Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study’, İstanbul Journal of Pharmacy, 55(1), pp. 1-9. https://doi.org/10.26650/IstanbulJPharm.2025.1547133 (17 Aug. 2025).


MLA

Demirpolat, Eren, and Nisa Güneş. “Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study.” İstanbul Journal of Pharmacy, vol. 55, no. 1, 2025, pp. 1-9. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2025.1547133


Vancouver

Demirpolat E, Güneş N. Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study. İstanbul Journal of Pharmacy [Internet]. 17 Aug. 2025 [cited 17 Aug. 2025];55(1):1-9. Available from: https://doi.org/10.26650/IstanbulJPharm.2025.1547133 doi: 10.26650/IstanbulJPharm.2025.1547133


ISNAD

Demirpolat, Eren - Güneş, Nisa. “Comparison and analysis of 4 drug interaction databases in nephrology patients using clinical pharmacy approaches: A crosssectional study”. İstanbul Journal of Pharmacy 55/1 (Aug. 2025): 1-9. https://doi.org/10.26650/IstanbulJPharm.2025.1547133



ZAMAN ÇİZELGESİ


Gönderim10.09.2024
Kabul14.01.2025
Çevrimiçi Yayınlanma07.05.2025

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ



İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.